All Commentary
Monday, October 26, 2009

Report Faults FDA for Failure to Follow through on Drugs


“The Food and Drug Administration has allowed drugs for cancer and other diseases to stay on the market even when follow-up studies showed they didn’t extend patients’ lives, say congressional investigators. A report due out Monday from the Government Accountability Office also shows that the FDA has never pulled a drug off the market due to a lack of required follow-up about its actual benefits — even when such information is more than a decade overdue.” (USA Today, Monday)

The FDA imprimatur gives a false sense of security.

FEE Timely Classic
“A World Without the FDA” by Russell Roberts


  • Sheldon Richman is the former editor of The Freeman and a contributor to The Concise Encyclopedia of Economics. He is the author of Separating School and State: How to Liberate America's Families and thousands of articles.